Objective: To evaluate the effectiveness and cost-effectiveness of the National PreCePT Programme (NPP) in increasing magnesium sulphate (MgSO4) in pre-term births.
Design: A quasi-experimental before-and-after design
Setting: Maternity units within NHS England and the AHSN network in 2018.
Participants: Maternity units in England (n=137) who participated in the NPP.
Interventions: NPP support which included the PReCePT QI toolkit and materials (pre-term labour proforma, staff training presentations, parent leaflet, posters for the unit, learning log), regional AHSN level support, and up to 90 hours funded backfill for a midwife champion to lead implementation.
Main outcome measures: MgSO4 post-implementation uptake compared to pre-implementation uptake. Implementation and lifetime costs were estimated.
Results: Compared to pre-implementation estimates, the average MgSO4 uptake in 137 maternity units in England increased by 6.3 percentage points (95% CI 2.6 to 10.0 percentage points) to 83.1% post-implementation, accounting for unit size, maternal, baby, and maternity unit factors, time trends, and AHSN. Further adjustment for early or late initiation of NPP activities increased the estimate to 9.5 percentage points (95% CI 4.3 to 14.7 percentage points). From a societal and lifetime perspective, the health gains and cost-savings associated with the NPP effectiveness generated a net monetary benefit of 866 GBP per preterm baby and the probability of the NPP being cost-effective was greater than 95%.
Conclusion: This national QI programme was effective and cost-effective. National programmes delivered via coordinated regional clinical networks can accelerate uptake of evidence-based therapies in perinatal care.